Tandem Diabetes Care, Inc.

U.S. healthcare company

TNDM Nasdaq ISIN US8753722037 SEC CIK 1438133 LEI 549300JEPFOD0K4D3I05
Follow Tandem Diabetes Care Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $283.7M +13.8% vs same quarter last year
Net income −$7.1M +66.5% vs same quarter last year
EPS, diluted −$0.10 +67.7% vs same quarter last year
Operating cash flow −$819K −109.9% vs same quarter last year
Revenue by quarter
$282.6M
$234.4M
$240.7M
$249.3M
$290.4M
$247.2M
$254.6M
$283.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1B−$204.7M
FY24$940.2M−$96M
FY23$747.7M−$222.6M
FY22$801.2M−$94.6M
FY21$702.8M$15.6M
FY20$498.8M−$34.4M
FY19$362.3M−$24.8M
FY18$183.9M−$122.6M
FY17$107.6M−$73M
FY16$84.2M−$83.4M
FY15$72.9M−$72.4M
FY14$49.7M−$79.5M
FY13$29M−$63.1M
FY12$2.5M−$33M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2553.8%−18.5%−20.2%
FY2452.1%−10.5%−10.2%
FY2349.2%−31.2%−29.8%
FY2251.5%−11.6%−11.8%
FY2153.5%3.2%2.2%
FY2052.2%−1.6%−6.9%
FY1953.6%−4.6%−6.8%
FY1848.9%−24.3%−66.7%
FY1741%−58.5%−67.9%
FY1628%−92.6%−99%
FY1536.5%−94.7%−99.4%
FY1430.7%−152.2%−159.9%
FY1321.3%−170.4%−217.7%
FY12−54.5%−1335.3%−1333.9%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$29.7M
FY24$5M
FY23−$58.6M
FY22$16.4M
FY21$97.2M
FY20−$2.7M
FY19$22.4M
FY18−$11.3M
FY17−$71.9M
FY16−$70.1M
FY15−$64.5M
FY14−$65.8M
FY13−$51.8M
FY12−$38M
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$10M$20M$30MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$0
FY24$30M
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Tandem Diabetes Care
  • Healthcare median
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTandem Diabetes CareHealthcare median
FY25−20.2%−30.6%
FY24−10.2%−47%
FY23−29.8%−58%
FY22−11.8%−80.4%
FY212.2%−71.8%
FY20−6.9%−62.2%
FY19−6.8%−46.2%
FY18−66.7%−49.6%
FY17−67.9%−45.9%
FY16−99%−36%
FY15−99.4%−37.8%
FY14−159.9%−35.5%
FY13−217.7%−37.1%
FY12−1333.9%−29.1%
FY11-−27.9%